openPR Logo
Press release

Global Drug Device Combination Market Report 2021: By Key Players, Application, Type, Market Share, Forecast to 2027

02-25-2021 11:49 AM CET | Health & Medicine

Press release from: Orion Market Reports

The Global Drug Device Combination Market size is expected to grow at an annual average of 5.3% during 2021-2027. A drug-device combination product is a medical device consisting of a device and active pharmaceutical ingredients that are physically or chemically bonded together as a "single entity". These products lead to safe and effective management and treatment of many disorders due to accurate drug delivery, topical administration and individualized treatment. Major drug-device combination products include drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems, and prefilled syringes. These technologically advanced products are used to manage and treat many chronic diseases such as cancer, diabetes, respiratory problems, cardiovascular disease, wound healing, and more.

(Get 15% Discount on Buying this Report)

A full report of Global Drug Device Combination Market is available at: https://www.orionmarketreports.com/drug-device-combination-market/47725/

The following players are covered in this report:
By Product
• Drug-eluting stent
• Infusion pump
• Photodynamic therapy
• Antimicrobial wound dressing
• Prefilled syringe

By Wound Type
• Cardiovascular disease
• Diabetes
• Respiratory problem
• Cancer treatment
• Antimicrobial application
• Other applications

By End User
• Hospital & clinic
• Ambulatory surgery center (ASC)
• Home care setting
• Other end users

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Scope of the Report
The research study analyses the global Drug Device Combination industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Drug Device Combination Market Report

1. What was the Drug Device Combination Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of Drug Device Combination Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Drug Device Combination Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr.Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:
Orion Market Reports (OMR) endeavours to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Drug Device Combination Market Report 2021: By Key Players, Application, Type, Market Share, Forecast to 2027 here

News-ID: 2248634 • Views:

More Releases from Orion Market Reports

Sodium Cromoglicate API Market to Expand With Strong Development by 2031
Sodium Cromoglicate API Market to Expand With Strong Development by 2031
The Sodium Cromoglicate API Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Sodium Cromoglicate API (active pharmaceutical ingredient) is a type of medication used to treat allergic conditions such as hay fever, allergic conjunctivitis, and asthma. It works by stabilizing mast cells and preventing the release of allergic substances that cause symptoms like itching, redness, and swelling. Sodium Cromoglicate API Market
Soda Ash and Aluminium Trihydrate (ATH) Market Will Generate Record Revenue by 2031
Soda Ash and Aluminium Trihydrate (ATH) Market Will Generate Record Revenue by 2 …
The Soda Ash and Aluminium Trihydrate (ATH) Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Soda Ash, also known as sodium carbonate, is a white, odorless powder used in manufacturing glass, detergents, chemicals, and other industrial applications. Aluminium Trihydrate (ATH) is a white, non-toxic powder primarily used as a flame retardant in plastics, rubber, and textiles. Soda Ash and Aluminium Trihydrate
Single Crystal Silicon Wafers Market Provides Information on Historical Growth, Analysis, Opportunities and Forecast To 2031
Single Crystal Silicon Wafers Market Provides Information on Historical Growth, …
The Single Crystal Silicon Wafers Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Single crystal silicon wafers are thin, disc-shaped substrates made from a single crystal of silicon. They are a fundamental component in the semiconductor industry and serve as the foundation for manufacturing integrated circuits (ICs) and other microelectronic devices. Single Crystal Silicon Wafers Market research analyzes the entire market,
Silicone For Personal Care Market Growth Drivers, Developments, Technology And Future Trends 2024-2031
Silicone For Personal Care Market Growth Drivers, Developments, Technology And F …
The Silicone For Personal Care Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Silicone for personal care refers to the use of silicone-based ingredients and formulations in various cosmetic and personal care products. Silicone compounds are valued in the personal care industry for their unique properties, including their smooth texture, excellent spreadability, water resistance, film-forming ability, and compatibility with skin

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug